Mass Spec to Drive Biomarker Research
A new report, "Biomarkers, The Expanding Global Market," by Piribo predicts that mass spectrometry will play a decisive role in accelerating protein biomarker research.
A new report, ?Biomarkers, The Expanding Global Market,? by Piribo predicts that mass spectrometry will play a decisive role in accelerating protein biomarker research. The global market for biomarkers is expected to be worth $5.6 billion in 2007, and is expected to increase to over $12.8 billion by 2012. Biomarker discovery technologies tailored to drug discovery, pre-clinical studies of drug development and diagnostics research applications accounted for 47.9% of the total in 2007, expected to reach a little less than $6 billion in 2012.
Mitigating High Sample Volume Consumption in AAV Aggregate Analysis Using a Biozen™ dSEC-7 by SEC-FL
April 15th 2024This application note showcases a Biozen dSEC-7 SEC chemistry/fluorescence detector solution, offering reliable AAV aggregate analysis in under 10 minutes with as little as 0.5 µL of sample. Across four AAV serotypes, resolution between monomer and aggregates remains consistently high, emphasizing Biozen dSEC-7's efficiency and ability to maintain accurate detection at minimal injection volumes. Ideal for routine testing, this solution ensures precise measurement of a CQA with streamlined sample consumption.
Adeno-Associated Virus (AAV) Serotype Screen Using a Biozen™ dSEC-7 Size Exclusion Column
April 15th 2024With its 700 Å large pore silica particle and hydrophilic diol-type surface chemistry, Biozen dSEC-7 provides excellent resolution of monomer from dimer peaks in under 8 minutes across four different AAV serotypes. This capability is crucial for optimizing gene therapy biopharmaceuticals, ensuring thorough analytical scrutiny to select the most appropriate serotype(s) for enhanced therapeutic outcomes and immunogenic profiles.
